Recombinant human growth hormone (Daewoong Pharmaceutical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human growth hormone (Daewoong Pharmaceutical)
Drug Alias NameCaretropin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsGrowth hormone deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/01/01
Country/TerritoryPhilippinesSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksN/A